1. Surveillance of Plasmodium vivax in new populations and expansion of the P. vivax elimination agenda to include sub-Saharan Africa |
2. Geospatial mapping of glucose 6-phosphate dehydrogenase deficiencies and CYP2D6 to gauge populations at risk of primaquine-induced hemolysis and poor efficacy |
3. Optimizing drug treatment of P. vivax, Plasmodium ovale, Plasmodium malariae, and Plasmodium knowlesi
|
4. Ensure effective radical cure of malaria through improved adherence or short-duration treatment regimens |
5. Reestablish field entomology as a core component of malariology |
6. Incorporation of ecology (including environmental control methods) into malaria planning, where appropriate |
7. Increase sampling of parasite reservoirs in areas with potential zoonotic transmission (human and nonhuman primate) and phylogeny of parasite populations to asses “spillover” |
8. Identification and optimization of strategies to target zoonotic malaria infections |
9. Greater emphasis on the basic biology of P. knowlesi, P. ovale, and P. malariae
|